Clinicopathologic Features of Prostate Adenocarcinoma Incidentally Discovered at the Time of Radical Cystectomy: An Evidence-Based Analysis

European Urology

Volumn 52, Issue 3, 2007, Pages 648-657

  Damiano, Rocco ^a   Di Lorenzo, Giuseppe ^b   Cantiello, Francesco ^a   De Sio, Marco ^c   Perdonà, Sisto ^d   D'Armiento, Massimo ^c   Autorino, Riccardo ^c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Bladder cancer; Cystoprostatectomy; Incidental; Prostate cancer; Prostatic intraepithelial neoplasia

Indexed keywords

ALPHA METHYL ACYL COENZYME A RACEMASE; KERATIN; RACEMASE; UNCLASSIFIED DRUG;

ACINAR CELL; AUTOPSY; BLADDER CANCER; CANCER INCIDENCE; CANCER SURVIVAL; CYSTECTOMY; DISEASE COURSE; EVIDENCE BASED MEDICINE; FOLLOW UP; GLEASON SCORE; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENTAL FINDING; MALE; MEDLINE; PRECANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; REVIEW; SYSTEMATIC REVIEW;

ADENOCARCINOMA; BIOPSY; CYSTECTOMY; HUMANS; INCIDENCE; INTRAOPERATIVE PERIOD; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 34547233183     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.06.016     Document Type: Review

References (59)

1. Stein J.P., and Skinner D.G. Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J Urol 24 (2006) 296-304
2. Spitz A., Stein J.P., Lieskovsky G., and Skinner D.G. Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique. J Urol 161 (1999) 1761-1764
3. Terrone C., Porpiglia F., Cracco C., et al. Supra-ampullar cystectomy and ileal neobladder. Eur Urol 50 (2006) 1223-1233
4. Muto G., Bardari F., D'Urso L., and Giona C. Seminal sparing cystectomy and ileocapsuloplasty: long-term follow-up results. J Urol 172 (2004) 76-80
5. Colombo R., Bertini R., Salonia A., et al. Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer. J Urol 171 (2004) 1819-1822
6. Vallancien G., Abou El Fettouh H., Cathelineau X., et al. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-years experience. J Urol 168 (2002) 2413-2417
7. Palou J., Baniel J., Klotz L., et al. Urothelial carcinoma of the prostate. Urology 69 Suppl 1A (2007) 50-61
8. Majeed A., Babb P., Jones J., and Quinn M. Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998. BJU Int 85 (2000) 1058-1062
9. Holund B. Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol 14 (1980) 29-35
10. Ruffion A., Manel A., Massoud W., et al. Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology 65 (2005) 703-707
11. Delongchamps N.B., Mao K., Theng H., et al. Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer. Eur Urol 48 (2005) 946-950
12. Liskow A.S., Neugut A.L., Benson M., Olsson C.A., Birkhoff J., and Chang C.H. Multiple primary neoplasms in association with prostate cancer in black and white patients. Cancer 59 (1987) 380-384
13. Sheldon C.A., Williams R.D., and Fraley E.E. Incidental carcinoma of the prostate: a review of the literature and critical appraisal of classification. J Urol 124 (1980) 626-631
14. Chun T.Y. Coincidence of bladder and prostate cancer. J Urol 157 (1997) 65-67
15. Kurokawa K., Ito K., Yamamoto T., et al. Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer. Urology 63 (2004) 268-272
16. Singh A., Kinoshita Y., Rovito P.M., et al. Higher than expected association of clinical prostate and bladder cancer. J Urol 173 (2005) 1526-1529
17. Singh A., Jones R.F., Friedman H., et al. Expression of p53 and pRb in bladder and prostate cancer in patients having both cancers. Anticancer Res 19 (1999) 5415-5417
18. Amara N., Palapattu G.C., Schrage M., et al. Prostate stem cell antigen is overexpressed on human transitional cell carcinoma. Cancer Res 61 (2001) 4660-4665
19. Noguchi M., Stamey T.A., McNeal J.E., and Yemoto C.E. Assessment of morphometric measurements of prostate carcinoma volume. Cancer 89 (2000) 1056-1064
20. Abbas F., Hochberg D., Civantos F., and Soloway M. Incidental prostatic adenocarcinoma in patients undergoing cystoprostatectomy for bladder cancer. Eur Urol 30 (1996) 322-326
21. Montie J.E., Wood Jr. D.P., Pontes J.E., Boyett J.M., and Levin H.S. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 63 (1989) 381-385
22. Conrad S., Hautmann S.H., Henke R.P., et al. Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients. Eur Urol 39 Suppl 4 (2001) 25-29
23. Revelo M.P., Cookson M.S., Chang S.S., et al. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 171 (2004) 646-651
24. Yang C.R., Ou Y.C., Ho H.C., et al. Unsuspected prostate carcinoma and prostatic intraepithelial neoplasm in Taiwanese patients undergoing cystoprostatectomy. Mol Urol 3 (1999) 33-39
25. Cindolo L., Benincasa G., Autorino R., et al. Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: a retrospective study. Oncol Rep 8 (2001) 269-271
26. Moutzouris G., Barbatis C., Plastiras D., et al. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder. Scand J Urol Nephrol 33 (1999) 27-30
27. Montironi R., Mazzucchelli R., Santinelli A., Scarpelli M., Lopez Beltran A., and Bostwick D.G. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol 36 (2005) 646-654
28. Lee S.H., Chang P.L., Chen S.M., et al. Synchronous primary carcinomas of the bladder and prostate. Asian J Urol 8 (2006) 357-359
29. Hsing A.W., Tsao L., and Devesa S.S. International trends and pattern of prostate cancer incidence and mortality. Int J Cancer 85 (2000) 60-67
30. Breslow N., Chan C.W., Dhom G., et al. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer 20 (1977) 680-688
31. Hayat M.J., Howlader N., Reichman M.E., and Edwards B.K. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 12 (2007) 20-37
32. Stamey T.A., Freiha F.S., McNeal J.E., Redwine E.A., Whittemore A.S., and Schmid H.P. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71 Suppl 3 (1993) 933-938
33. Epstein J.I., Chan D.W., Sokoll L.J., et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol 160 (1998) 2407-2411
34. Irwin M.B., and Trapasso J.G. Identification of insignificant prostate cancer: analysis of preoperative parameters. Urology 44 (1994) 862-867
35. Stamey T.A., Johnstone I.M., McNeal J.E., et al. Preoperative serum prostate specific antigen levels between 2 and 22 ng/ml correlate poorly with post prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng/ml. J Urol 167 (2002) 103-111
36. Prange W., Erbersdobler A., Hammerer P., et al. High grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens. Eur Urol 39 Suppl 4 (2001) 30-31
37. Abdelhady M., Abusamra A., Pautler S.E., Chin L., and Izawa J.I. Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens. BJU Int 99 (2007) 326-329
38. Ward J.F., Bartsch G., Sebo T.J., Pinggerra G.M., Blute M.L., and Zincke H. Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/ml) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance?. Urol Oncol 22 (2004) 40-47
39. Montironi R., Mazzucchelli R., Barbisan F., et al. HER2 expression and gene amplification in pT2 Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer. Hum Pathol 37 (2006) 1137-1144
40. Bostwick D.G. Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma. Eur Urol 30 (1996) 145-152
41. Epstein J.L., and Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 175 (2006) 820-834
42. Wiley E.L., Davidson P., McIntire D.D., and Sagalowsky A.I. Risk of concurrent prostate cancer in cystoprostatectomy specimens is related to volume of high-grade prostatic intraepithelial neoplasia. Urology 46 (1997) 692-696
43. Aydin O., Cosar E.F., Varinli S., Bugdatci R., and Tansung Z. Prostatic intraepithelial neoplasia in prostate specimens: frequency, significance and relationship to the sampling of the specimen (a retrospective study of 121 cases). Int Urol Nephrol 31 (1999) 687-697
44. Montironi R., Scattoni V., Mazzucchelli R., et al. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy"). Eur Urol 50 (2006) 666-674
45. Bostwick D.G., and Meiers I. Atypical small acinar proliferation in the prostate: clinical significance in 2006. Arch Pathol Lab Med 130 (2006) 952-957
46. Flury S.C., Galganot M.T., Mills S.E., Smolkin M.E., and Theodorescu D.T. Atypical small acinar proliferation: biopsy artefact or distinct pathological entity?. BJU Int 99 (2007) 780-785
47. Androulakakis P.A., Schneider H.M., Jacobi G.H., and Hohenfellner R. Coincident vesical transitional cell carcinoma and prostatic carcinoma: clinical features and treatment. Br J Urol 58 (1986) 153-156
48. Pritchett T.R., Moreno J., Warner N.E., et al. Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. J Urol 139 (1988) 1214-1216
49. Konski A., Rubin P., Disantagnese P.A., Mayer E., and Keys H. Simultaneous presentation of adenocarcinoma of prostate and transitional cell carcinoma of bladder. Urology 37 (1991) 202-206
50. Kouriefs C., Fazili T., Masood S., Naseem M.S., and Mufti G.R. Incidentally detected prostate cancer in cystoprostatectomy specimens. Urol Int 75 (2005) 213-216
51. Stamey T., Caldwell M., McNeal J.E., Nolley R., Hemenez M., and Downs J. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?. J Urol 172 (2004) 1297-1301
52. Thompson I.M., Pauler D.K., Goodman P., et al. Prevalence of prostate cancer among men with a prostate specific antigen level < or = 4.0 ng/ml. N Engl J Med 350 (2004) 2239-2246
53. Terris M.K., Freiha F.S., McNeal J.E., and Stamey T.A. Efficacy of clinically undetected prostate cancer. J Urol 146 (1991) 78-83
54. Winkler M.H., Livni N., Mannion E.M., et al. Characteristic of prostatic incidental adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJU Int 99 (2007) 554-558
55. Rocco B., de Cobelli O., Leon M.E., et al. Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report. Eur Urol 49 (2006) 827-833
56. Fahmy N.M., Mahmud S., and Aprikian A.G. Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature. Eur Urol 50 (2006) 1176-1182
57. Kefer J.C., Voelzke B.B., Flanigan R.C., et al. Risk assessment for occult malignancy in the prostate before radical cystectomy. Urology 66 (2005) 1251-1255
58. Koraitim M.M., Atta M., and Foda M.K. Impact of the prostatic apex on continence and urinary flow in patients with intestinal neobladders. Br J Urol 78 (1996) 534-536
59. Aus G. Current status of HIFU and cryotherapy in prostate cancer-a review. Eur Urol 50 (2006) 927-934